Zhejiang Starry Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 1,046.415 million compared to CNY 985.738 million a year ago. Operating income was CNY 256.361 million compared to CNY 183.826 million a year ago. Net income was CNY 198.449 million compared to CNY 137.433 million a year ago. Basic earnings per share from continuing operations was CNY 0.84 compared to CNY 0.58 a year ago.